Israel Englander Codex Dna, Inc. Transaction History

Millennium Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	N/A	-65,129 Reduced 21.89%	232,395 $429,000
Q4 2023 Feb 14, 2024	BUY	N/A	45,854 Added 18.22%	297,524 $550,000
Q2 2023 Aug 14, 2023	SELL	N/A	-92,381 Reduced 26.85%	251,670 $465,000
Q1 2023 May 15, 2023	SELL	$1.3 - $2.15 $16,629 - $27,502	-12,792 Reduced 3.58%	344,051 $1.07 Million
Q4 2022 Feb 14, 2023	SELL	$1.12 - $1.69 $9,377 - $14,150	-8,373 Reduced 2.29%	356,843 $446,000
Q3 2022 Nov 14, 2022	SELL	$1.7 - $2.36 $116,290 - $161,438	-68,406 Reduced 15.78%	365,216 $606,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.